Ken Griffin Concert Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $1.17 Million - $1.58 Million	269,873 Added 24.07%	1,391,302 $8.13 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $2.26 Million - $3.82 Million	530,305 Added 89.71%	1,121,429 $7.51 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $1.6 Million - $3.63 Million	570,731 Added 2798.66%	591,124 $2.49 Million
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $149,852 - $216,270	-54,891 Reduced 72.91%	20,393 $69,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $173,523 - $272,219	64,507 Added 598.56%	75,284 $237,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $28,701 - $39,892	-7,613 Reduced 41.4%	10,777 $45,000
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $261,166 - $702,355	-53,738 Reduced 74.5%	18,390 $92,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $177,037 - $387,529	-29,605 Reduced 29.1%	72,128 $637,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $244,941 - $395,510	-42,897 Reduced 29.66%	101,733 $939,000
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $391,119 - $821,484	66,517 Added 85.15%	144,630 $850,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $326,454 - $453,715	34,582 Added 79.44%	78,113 $937,000
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $55,497 - $80,648	4,598 Added 11.81%	43,531 $0
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $422,932 - $607,894	-37,594 Reduced 49.13%	38,933 $488,000
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $309,372 - $431,480	-24,132 Reduced 23.97%	76,527 $0
Q2 2018 Aug 10, 2018	SELL	$16.83 - $21.66 $1.04 Million - $1.34 Million	-61,927 Reduced 38.09%	100,659 $0
Q1 2018 May 11, 2018	BUY	$19.24 - $28.03 $1.78 Million - $2.6 Million	92,625 Added 132.4%	162,586 $3.72 Million
Q4 2017 Feb 09, 2018	SELL	$13.96 - $29.05 $763,863 - $1.59 Million	-54,718 Reduced 43.89%	69,961 $1.81 Million
Q3 2017 Nov 09, 2017	BUY	$13.91 - $15.31 $1.73 Million - $1.91 Million	124,679	124,679 $1.84 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account